Comorbidity as an Independent Prognostic Factor in Elderly Patients With Peripheral T-Cell Lymphoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s93687
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2014English

Global Hypomethylation Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma

American Journal of Hematology
Hematology
2017English

The Derived Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Circulating Levels of TNF Receptor II Are Prognostic for Patients With Peripheral T-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Pretherapeutic Gamma-Glutamyltransferase Is an Independent Prognostic Factor for Patients With Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2014English

Peripheral T Cell Lymphoma Presenting With Hypereosinophilia

Medical Journal Armed Forces India
Medicine
2008English

T-Cell Lymphoma in the Elderly Patients. Who Is Young, Old, and Elderly?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy